Jei-ming Peng
Kaohsiung, KHQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Oncogenic PIK3CA mutation enhances tumor immunogenicity through the IRF1-NLRC5-MHC-I axis in urothelial carcinoma.
Journal: Journal for immunotherapy of cancer
Published: June 15, 2026
Correction: Peng, J.-M.; Liu, H.-Y. CD300a: An Innate Immune Checkpoint Shaping Tumor Immunity and Therapeutic Opportunity. Cancers 2025, 17, 1786.
Journal: Cancers
Published: November 03, 2025
Pre-Treatment BOC Expression as an Indicator of Lymphovascular Invasion and In Vitro Chemotherapeutic Response in Upper Tract Urothelial Carcinoma.
Journal: Oncology research
Published: July 25, 2025
CD300a: An Innate Immune Checkpoint Shaping Tumor Immunity and Therapeutic Opportunity.
Journal: Cancers
Published: May 01, 2025
Low-energy extracorporeal shockwave therapy improves locomotor functions, tissue regeneration, and modulating the inflammation induced FGF1 and FGF2 signaling to protect damaged tissue in spinal cord injury of rat model: an experimental animal study.
Journal: International journal of surgery (London, England)
Published: May 22, 2024
Lymph node metastasis and tumor-educated immune tolerance: Potential therapeutic targets against distant metastasis.
Journal: Biochemical pharmacology
Published: March 18, 2023
VCAN Hypomethylation and Expression as Predictive Biomarkers of Drug Sensitivity in Upper Urinary Tract Urothelial Carcinoma.
Journal: International journal of molecular sciences
Published: February 24, 2023
Evasion of NK cell immune surveillance via the vimentin-mediated cytoskeleton remodeling.
Journal: Frontiers in immunology
Published: February 24, 2022
Pathological, Morphometric and Correlation Analysis of the Modified Mankin Score, Tidemark Roughness and Calcified Cartilage Thickness in Rat Knee Osteoarthritis after Extracorporeal Shockwave Therapy.
Journal: International journal of medical sciences
Published: October 04, 2021
Dysregulation of Cytoskeleton Remodeling Drives Invasive Leading Cells Detachment.
Journal: Cancers
Published: September 20, 2021
Last Updated: 09/26/2026